130 related articles for article (PubMed ID: 11205577)
1. [Non-Hodgkin's lymphomas: current aspects].
Rozman C
Rev Neurol; 2000 Dec 16-31; 31(12):1275-80. PubMed ID: 11205577
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
3. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
5. [Stomach lymphomas: minimum diagnostic requirements for gastrointestinal histopathological diagnosis].
Doglioni C; Savio A; Ranaldi R; Magrini U;
Pathologica; 2001 Feb; 93(1):61-70. PubMed ID: 11294022
[TBL] [Abstract][Full Text] [Related]
6. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
Ferrucci PF; Zucca E
Br J Haematol; 2007 Feb; 136(4):521-38. PubMed ID: 17156403
[TBL] [Abstract][Full Text] [Related]
7. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
Krivolapov IuA
Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
[TBL] [Abstract][Full Text] [Related]
8. [Non-hodgkin's lymphomas].
Drouet F; Cahu X; Pointreau Y; Denis F; Mahé MA
Cancer Radiother; 2010 Nov; 14 Suppl 1():S210-29. PubMed ID: 21129666
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
10. [MALT-type non-Hodgkin's lymphoma: advances in biopsy diagnosis and pathogenesis].
Ott G; Greiner A
Verh Dtsch Ges Pathol; 1999; 83():79-89. PubMed ID: 10714198
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma.
Wöhrer S; Streubel B; Bartsch R; Chott A; Raderer M
Clin Cancer Res; 2004 Nov; 10(21):7179-81. PubMed ID: 15534090
[TBL] [Abstract][Full Text] [Related]
16. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
18. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
19. Concurrent low grade B-cell non-Hodgkin's lymphoma of MALT type arising in the large intestine, small intestine and stomach.
Venizelos J; Tamiolakis D; Nikolaidou S; Lambropoulou M; Alexiadis G; Papadopoulos N
Chirurgia (Bucur); 2007; 102(1):99-101. PubMed ID: 17410739
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-art therapeutics: marginal-zone lymphoma.
Bertoni F; Zucca E
J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
